129 related articles for article (PubMed ID: 12799027)
1. Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells.
Zhang W; Liu JL; Meager A; Newsom-Davis J; Willcox N
J Neuroimmunol; 2003 Jun; 139(1-2):102-8. PubMed ID: 12799027
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
3. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
4. Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma.
Yoshikawa H; Sato K; Edahiro S; Furukawa Y; Maruta T; Iwasa K; Watanabe H; Takaoka S; Suzuki Y; Takamori M; Yamada M
J Neuroimmunol; 2006 Jun; 175(1-2):169-75. PubMed ID: 16574246
[TBL] [Abstract][Full Text] [Related]
5. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease.
Meager A; Vincent A; Newsom-Davis J; Willcox N
Lancet; 1997 Nov; 350(9091):1596-7. PubMed ID: 9393342
[No Abstract] [Full Text] [Related]
7. Absence of IFN-gamma or IL-12 has different effects on experimental myasthenia gravis in C57BL/6 mice.
Karachunski PI; Ostlie NS; Monfardini C; Conti-Fine BM
J Immunol; 2000 May; 164(10):5236-44. PubMed ID: 10799884
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G
Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749
[TBL] [Abstract][Full Text] [Related]
9. [A case of thymoma-associated myasthenia gravis with antibodies against interferon-alpha--a clinico-immunological follow up of the symptoms and its titer].
Nakamori M; Matsumura T; Saito T; Kunitomi A; Iyama A; Nozaki S; Fujimura H; Shinno S
Rinsho Shinkeigaku; 2003 Sep; 43(9):544-7. PubMed ID: 14727560
[TBL] [Abstract][Full Text] [Related]
10. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
[TBL] [Abstract][Full Text] [Related]
11. CD8+ immunoregulatory cells in the graft-versus-host reaction: CD8 T cells activate dendritic cells to secrete interleukin-12/interleukin-18 and induce T helper 1 autoantibody.
Noble A; Leggat JA; Inderberg EM
Immunology; 2003 Aug; 109(4):476-86. PubMed ID: 12871213
[TBL] [Abstract][Full Text] [Related]
12. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
[TBL] [Abstract][Full Text] [Related]
13. Epitopes expressed in myasthenia gravis (MG) thymomas are not recognized by patients' T cells or autoantibodies.
Nagvekar N; Jacobson LW; Willcox N; Vincent A
Clin Exp Immunol; 1998 Apr; 112(1):17-20. PubMed ID: 9566784
[TBL] [Abstract][Full Text] [Related]
14. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
Yi Q; Lefvert AK
J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
[TBL] [Abstract][Full Text] [Related]
15. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
16. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells.
Kaliński P; Schuitemaker JH; Hilkens CM; Wierenga EA; Kapsenberg ML
J Immunol; 1999 Mar; 162(6):3231-6. PubMed ID: 10092774
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells activate autologous T cells and induce IL-4 and IL-10 production in myasthenia gravis.
Adikari SB; Lefvert AK; Pirskanen R; Press R; Link H; Huang YM
J Neuroimmunol; 2004 Nov; 156(1-2):163-70. PubMed ID: 15465607
[TBL] [Abstract][Full Text] [Related]
18. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
19. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients.
Tackenberg B; Schlegel K; Happel M; Eienbröker C; Gellert K; Oertel WH; Meager A; Willcox N; Sommer N
J Neuroimmunol; 2009 Nov; 216(1-2):85-91. PubMed ID: 19781791
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
